Acurx Pharmaceuticals, Inc. SEC filings ACXP

Acurx Pharmaceuticals, Inc. has 245 filings in SEC EDGAR's recent list, going back to Apr 3, 2018. Its latest annual report, Form ARS, was filed on Sep 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (bylaw or fiscal year change). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Sep 1, 2026 —
DEF 14A Proxy statement Sep 1, 2026 Oct 16, 2026
DEFA14A Additional proxy material Aug 5, 2025 —
DEF 14A Proxy statement Aug 4, 2025 Sep 16, 2025
PRE 14A Preliminary proxy statement Jul 24, 2025 Sep 16, 2025
DEFA14A Additional proxy material May 29, 2025 —
DEF 14A Proxy statement May 29, 2025 Jul 17, 2025
PRE 14A Preliminary proxy statement May 19, 2025 Jul 17, 2025
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 17, 2024
DEFA14A Additional proxy material Apr 27, 2023 —
DEF 14A Proxy statement Apr 27, 2023 Jun 15, 2023
PRE 14A Preliminary proxy statement Apr 17, 2023 Jun 15, 2023
DEFA14A Additional proxy material Apr 25, 2022 —
DEF 14A Proxy statement Apr 25, 2022 Jun 7, 2022

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ACXP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Staten Island, NY
SEC filer status
, Emerging growth company
SEC CIK
1736243
Former names
Acurx Pharmaceuticals, LLC (until Jun 23, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.